Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer

Brachytherapy(2025)10.1016/j.brachy.2025.09.011Source: DataRank Database

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer is a research paper published in Brachytherapy (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.09)OA: greenTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Wei Deng ORCID,Dmitriy Zamarin ORCID,Ying Xiao ORCID,Junzo Chino ORCID,Stanley Benedict ORCID

Live enrichment

PubMed:41107078 PMC:PMC12971087 OpenAlex:https://openalex.org/W4415256483

NCI NIH HHS

Grant: U10 CA180822

NCI NIH HHS

Grant: U24 CA196067

NCI NIH HHS

Grant: U24 CA180803

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: R01 CA276087

NCI NIH HHS

Grant: R50 CA282102

NCI NIH HHS

Grant: U10 CA180868

National Institutes of Health National Cancer Institute

Genentech

FWCI

2.09

Citation Percentile

0.9%

Citation Trend

2026

greenLicense: cc-by-nc-nd

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12971087/pdf/nihms-2144625.pdf

GREENhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12971087/pdf/nihms-2144625.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12971087/pdf/nihms-2144625.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538472125003125?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538472125003125?httpAccept=text/plain

Fields of Study

Endometrial and Cervical Cancer TreatmentsHER2/EGFR in Cancer ResearchCancer Immunotherapy and BiomarkersMedicineEngineeringHumansFemaleUterine Cervical NeoplasmsBrachytherapyRadiotherapy, Image-GuidedQuality Assurance, Health CareChemoradiotherapyImmunotherapyAntibodies, Monoclonal, HumanizedRadiotherapy DosageRadiotherapy Planning, Computer-Assisted

MeSH Terms

BrachytherapyUterine Cervical NeoplasmsFemaleHumansImmunotherapyQuality Assurance, Health CareRadiotherapy DosageRadiotherapy Planning, Computer-AssistedChemoradiotherapyAntibodies, Monoclonal, HumanizedRadiotherapy, Image-Guided

Keywords

Quality assuranceCervical cancerBrachytherapyClinical trialImmunotherapyRadiation therapyRadiationPeer ReviewClinical Trials

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer

FAIR Checklist

Authors (23)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)